Revamped Anemia-Free India Campaign: New Guidelines Unveiled

Newspoint
Introduction of New Guidelines


The Central Government has made notable updates to the 'Anemia Mukt Bharat' initiative aimed at eradicating anemia in India. Recently, new operational guidelines were released to expedite the reduction of anemia cases nationwide. The previous '6×6×6' strategy has now evolved into a '7×7×7' approach, as announced by Union Minister for Health and Family Welfare J.P. Nadda during the 16th Central Council of Health and Family Welfare meeting.


Hero Image
Inclusion of New Beneficiary Groups

With the updated strategy, the campaign will now also focus on low-birth-weight infants aged zero to six months. This inclusion aims to enhance anemia prevention and treatment from the earliest stages of life.


Key Features of the New Guidelines

The government emphasizes that the initiative will be more comprehensive, focusing on people and leveraging technology. The campaign will extend beyond just distributing iron tablets to include screening, treatment, nutritional support, digital tracking, and community involvement.


For the first time, low-birth-weight infants will be recognized as a distinct beneficiary group, while 'Eating Right'—promoting a balanced, iron-rich diet—has been introduced as a crucial intervention to encourage daily nutritious eating habits.


A strong monitoring and evaluation framework, enhanced by digital tracking, has been established as the seventh institutional mechanism.


Transition to a New Service Delivery Model

Shift from T-3 to T-4 Model


The service delivery model has also been updated. The previous 'Test, Treat, and Talk' (T-3) model will now be replaced by the 'Test, Treat, Talk, and Track' (T-4) model.


This new model will prioritize hemoglobin testing, treatment for iron-deficiency anemia, ongoing patient monitoring, and nutritional counseling. Additionally, provisions have been made for administering ferric carboxymaltose and iron sucrose intravenously to pregnant and lactating women who are severely anemic or do not respond to oral iron supplements.